By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Othera Pharmaceuticals 

730 Springdale Drive

Exton  Pennsylvania  19341  U.S.A.
Phone: 484-879-2800 Fax: 484-879-2801


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Colby Pharmaceutical Acquires Othera Pharmaceuticals 9/19/2012 10:08:08 AM
Othera Pharmaceuticals Reports Preserved Visual Function in Clinical Trial of OT-551 Eye Drop Treatment for Advanced Dry AMD 3/23/2010 12:45:58 PM
Othera Pharmaceuticals Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD 4/8/2009 12:47:41 PM
Othera Pharmaceuticals Announces First U.S. Patent Issued On New Class of Compounds to Treat AMD and Other Ophthalmic Diseases 10/28/2008 8:36:32 AM
Othera Pharmaceuticals Initiates Phase I/II Clinical Trial of OT-730 In Ocular Hypertension and Glaucoma 9/15/2008 8:39:56 AM
Othera Pharmaceuticals Files IND Application for OT-730 in Glaucoma 7/30/2008 9:41:26 AM
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer 10/2/2007 10:20:37 AM
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer 10/1/2007 8:27:27 AM
Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals 9/26/2007 12:52:16 PM
Othera Pharmaceuticals and the National Eye Institute Reach Target Enrollment in Dry AMD Clinical Trial with OT-551 Eye Drops 6/18/2007 2:23:48 PM
123
//-->